ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MBX vs ZLAB // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

MBX Biosciences Inc. (NASDAQ) VS. Zai Lab Limited (NASDAQ) • 15-METRIC TALLY: MBX 4 — ZLAB 1
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MBX VS. ZLAB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MBX ZLAB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 58.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -26.40% -35.00% +8.60 MBX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -3.12% -6.33% +3.21 MBX /fcf-yield <GO>
Operating Margin — -50.20% — TIE /operating-margins <GO>
Net Profit Margin — -38.40% — TIE /net-margins <GO>
Revenue Growth (YoY) — 15.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.52 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 5/9 -3.00 ZLAB /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.8 40.3 +13.54 MBX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.63B $2.51B $116.4M MBX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MBX REV ZLAB REV MBX GROSS % ZLAB GROSS % MBX FCF ZLAB FCF
FY 2025 $0 $457.2M — 58.3% -$81.9M -$158.9M
FY 2024 $0 $397.6M — 63.0% -$55.6M -$220.5M
FY 2023 $0 $266.7M — — -$32.0M -$198.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MBX // BETA —
ZLAB // BETA —